Literature DB >> 5075365

Chemotherapy of thyroid cancer. An evaluation of experience with 37 patients.

J A Gottlieb, C S Hill, M L Ibanez, R L Clark.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 5075365     DOI： 10.1002/1097-0142(197209)30:3<848::aid-cncr2820300336>3.0.co;2-2

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  15 in total

1.  Inhibition of the Ras/Raf/MEK/ERK and RET kinase pathways with the combination of the multikinase inhibitor sorafenib and the farnesyltransferase inhibitor tipifarnib in medullary and differentiated thyroid malignancies.

Authors:  David S Hong; Maria E Cabanillas; Jennifer Wheler; Aung Naing; Apostolia M Tsimberidou; Lei Ye; Naifa L Busaidy; Steven G Waguespack; Mike Hernandez; Adel K El Naggar; Alder K El Naggar; Savita Bidyasar; John Wright; Steven I Sherman; Razelle Kurzrock
Journal:  J Clin Endocrinol Metab       Date:  2011-02-02       Impact factor: 5.958

2.  Combined chemotherapy with bleomycin, adriamycin, and platinum in advanced thyroid cancer.

Authors:  P De Besi; B Busnardo; S Toso; M E Girelli; D Nacamulli; N Simioni; D Casara; P Zorat; M V Fiorentino
Journal:  J Endocrinol Invest       Date:  1991-06       Impact factor: 4.256

Review 3.  Advances in the management of MEN2: from improved surgical and medical treatment to novel kinase inhibitors.

Authors:  Samuel A Wells
Journal:  Endocr Relat Cancer       Date:  2017-11-15       Impact factor: 5.678

4.  Poorly differentiated neoplasms of the thyroid gland.

Authors:  C G Thomas; J A Buckwalter
Journal:  Ann Surg       Date:  1973-05       Impact factor: 12.969

5.  Response to undifferentiated thyroid carcinoma to combined modality treatment.

Authors:  J G Brun; Y Barre; T Barre; M Mogenet; J Reynier
Journal:  World J Surg       Date:  1979-08-31       Impact factor: 3.352

Review 6.  Standard and emerging therapies for metastatic differentiated thyroid cancer.

Authors:  Christine J O'Neill; Jennifer Oucharek; Diana Learoyd; Stan B Sidhu
Journal:  Oncologist       Date:  2010-02-08

7.  Post-operative diagnosis and therapy of thyroid carcinoma by nuclear medicine.

Authors:  H Hundeshagen
Journal:  Eur J Nucl Med       Date:  1983

8.  Chemotherapy of thyroid carcinoma.

Authors:  S Ahuja; H Ernst
Journal:  J Endocrinol Invest       Date:  1987-06       Impact factor: 4.256

9.  Bcl-2 and c-Myc, but not bax and p53, are expressed during human medullary thyroid tumorigenesis.

Authors:  D G Wang; W H Liu; C F Johnston; J M Sloan; K D Buchanan
Journal:  Am J Pathol       Date:  1998-06       Impact factor: 4.307

10.  [Reoperation in carcinoma of the thyroid (author's transl)].

Authors:  G Heberer
Journal:  Langenbecks Arch Chir       Date:  1976-11-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.